Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.35 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.33 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 3/20 | 0.32 |
| ▸ | POLB | P06746 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1758934 | 1.00 | CA2 (0.38) | CA2ALOX12GABRA1GABRB2ALDH1A1 | |
| SCHEMBL30132730 | 0.80 | ALDH1A1 (0.44) | CA2ALOX12ALDH1A1TSHRTDP1 | |
| SCHEMBL242955 | 0.80 | CA2 (0.46) | CA2ALOX12GABRA1GABRB2ALDH1A1 | |
| SCHEMBL242956 | 0.80 | CA2 (0.46) | CA2ALOX12GABRA1GABRB2ALDH1A1 | |
| SCHEMBL23644549 | 0.75 | MEN1 (0.35) | CA2ALDH1A1TSHRTDP1GAA | |
| SCHEMBL6558817 | 0.75 | MEN1 (0.35) | CA2ALDH1A1TSHRTDP1GAA | |
| SCHEMBL20954046 | 0.74 | CA2 (0.44) | CA2ALOX12GABRA1GABRB2ALDH1A1 | |
| SCHEMBL20211348 | 0.74 | CA2 (0.44) | CA2ALOX12GABRA1GABRB2ALDH1A1 | |
| SCHEMBL7927338 | 0.70 | GABRA1 (0.38) | CA2GABRA1GABRB2ALDH1A1TSHR | |
| SCHEMBL23644535 | 0.70 | GABRA1 (0.38) | CA2GABRA1GABRB2ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110108769-A1 | Complexes for Use In Optoelectronic Components | MERCK PATENT GMBH (DE) | 2011-05-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110108769-A1 | Complexes for Use In Optoelectronic Components | OSTC, INTS9, NBAS | CA2 3282/4885ALOX12 2083/4885GABRA1 2902/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.